Akoya Biosciences stock target cut, rating held on recent earnings report
AKYA Stock | USD 2.14 0.06 2.73% |
About 67% of Akoya Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Akoya Biosciences stock suggests that many investors are alarmed at this time. The current market sentiment, together with Akoya Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Akoya Biosciences stock news signals to limit their universe of possible portfolio assets.
Akoya |
Akoya Biosciences stock target cut, rating held on recent earnings report
Read at investing.com
Akoya Biosciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Akoya Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Akoya Biosciences Fundamental Analysis
We analyze Akoya Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akoya Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akoya Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Akoya Biosciences is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Akoya Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Akoya Biosciences stock to make a market-neutral strategy. Peer analysis of Akoya Biosciences could also be used in its relative valuation, which is a method of valuing Akoya Biosciences by comparing valuation metrics with similar companies.
Peers
Akoya Biosciences Related Equities
MLSS | Milestone Scientific | 2.00 | ||||
PDEX | Pro Dex | 1.47 | ||||
ICUI | ICU Medical | 1.27 | ||||
ATRC | AtriCure | 1.06 | ||||
COO | Cooper Companies, | 0.77 | ||||
ANGO | AngioDynamics | 0.43 | ||||
LMAT | LeMaitre Vascular | 0.35 | ||||
UTMD | Utah Medical | 0.03 | ||||
ATR | AptarGroup | 0.18 | ||||
HAE | Haemonetics | 0.72 | ||||
INFU | InfuSystems Holdings | 1.01 |
Complementary Tools for Akoya Stock analysis
When running Akoya Biosciences' price analysis, check to measure Akoya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akoya Biosciences is operating at the current time. Most of Akoya Biosciences' value examination focuses on studying past and present price action to predict the probability of Akoya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akoya Biosciences' price. Additionally, you may evaluate how the addition of Akoya Biosciences to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Stocks Directory Find actively traded stocks across global markets |